Company
Every investor coverage indicates participated in a round Mater Research Institute-UQ raised.
Companies Mater Research Institute-UQ acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Katharina Ronacher | Honorary Professor | Business News Australia, @AuManufacturing |
Stories naming Mater Research Institute-UQ. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.